Kuros Biosciences Full Year 2024 Earnings: CHF0.12 loss per share (vs CHF0.38 loss in FY 2023)

Simply Wall St · 03/12 04:12

Kuros Biosciences (VTX:KURN) Full Year 2024 Results

Key Financial Results

  • Revenue: CHF75.6m (up 125% from FY 2023).
  • Net loss: CHF3.72m (loss narrowed by 73% from FY 2023).
  • CHF0.12 loss per share (improved from CHF0.38 loss in FY 2023).
earnings-and-revenue-history
SWX:KURN Earnings and Revenue History March 12th 2025

All figures shown in the chart above are for the trailing 12 month (TTM) period

Kuros Biosciences shares are down 6.2% from a week ago.

Risk Analysis

It is worth noting though that we have found 2 warning signs for Kuros Biosciences that you need to take into consideration.